advertisement

Topcon

3.5 Molecular biology incl. SiRNA (10)

Showing records 1 to 10

Display all abstracts in classification 3.5 Molecular biology incl. SiRNA

Search within classification 3.5 Molecular biology incl. SiRNA
23838 Increased RhoA and RhoB protein accumulation in cultured human trabecular meshwork cells by lovastatin
Von Zee CL; Richards MP; Bu P; Perlman JI; Stubbs EB Jr
Investigative Ophthalmology and Visual Science 2009; 50: 2816-2823
23471 Myocilin is a modulator of Wnt signaling
Kwon H-S; Lee H-S; Ji Y; Rubin JS; Tomarev SI
Molecular and Cellular Biology 2009; 29: 2139-2154
23718 Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-beta2 signaling
Fuchshofer R; Stephan DA; Russell P; Tamm ER
Experimental Eye Research 2009; 88: 1020-1032
23524 Pro370Leu mutant myocilin impairs mitochondrial functions in human trabecular meshwork cells
He Y; Leung KW; Zhuo Y-H; Ge J
Molecular Vision 2009; 15:- 815-825
23528 Elevated hydrostatic pressure triggers release of OPA1 and cytochrome C, and induces apoptotic cell death in differentiated RGC-5 cells
Ju W-K; Kim K-Y; Lindsey JD; Angert M; Patel A; Scott RT; Liu Q; Crowston JG; Ellisman MH; Perkins GA
Molecular Vision 2009; 15:- 120-134
23775 A clinical and molecular genetic study of German patients with primary congenital glaucoma
Weisschuh N; Wolf C; Wissinger B; Gramer E
American Journal of Ophthalmology 2009; 147: 744-753
23706 Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations
Schlötzer-Schrehardt U
Experimental Eye Research 2009; 88: 776-785
23529 TNF-α-308 G>A and -238 G>A polymorphisms are not major risk factors in Caucasian patients with exfoliation glaucoma
Mossbock G; Renner W; El-Shabrawi Y; Faschinger C; Schmut O; Wedrich A; Zimmermann C; Weger M
Molecular Vision 2009; 15:- 518-522
23525 Anti-inflammatory effect of pigment epithelium-derived factor in DBA/2J mice
Zhou X; Li F; Kong L; Chodosh J; Cao W
Molecular Vision 2009; 15:- 438-450
23605 New treatments for ocular hypertension
Mediero A; Alarma-Estrany P; Pintor J
Auton Neuroscience 2009; 147:-2 14-19

Issue 11-2

Change Issue


advertisement

Oculus